A research team at the Department of Pathology, LKS Faculty of Medicine, The University of Hong Kong (HKUMed) in collabo...
New South Wales (NSW) will leverage its world-class cell and gene therapy expertise to establish Australia’s first...
Two research teams from The Hong Kong Polytechnic University (PolyU) found that not only did the rate of myopia progress...
Researchers in Australia have discovered a way to kill a type of bacteria that causes millions of respiratory infections...
The translation of research into the development of innovative and life-saving microbial therapies is set to transform i...
US-based ENDRA Life Sciences Inc. has received Institutional Review Board approval from China’s Shanghai...
Scientists at Nanyang Technological University, Singapore (NTU Singapore) have developed a new therapeutic approach to o...
Researchers from Monash University in Australia have discovered a potential new way to prevent antibiotic resistance and...
A study led by Hong Kong Baptist University (HKBU) has revealed that different degrees of exposure to bisphenol S (BPS),...
Federal Minister for Health, Greg Hunt has announced funding for two new Research Centres through the MTPConnect Targete...
In a study jointly conducted by the Bio-Safety Level 3 (BSL3) Core Facility at the NUS Yong Loo Lin School of Medicine (...
An interdisciplinary research team from The Hong Kong Polytechnic University (PolyU) has successfully developed the worl...
Software-analysed high-resolution videos have revealed that dengue-infected mosquitos are more attracted to mammals and ...
Scientists have pinpointed a gene that helps deadly E. coli bacteria evade antibiotics, potentially leading to better tr...
Singapore-based SCG Cell Therapy has acquired the rights to human “induced pluripotent stem cell” ...
The University of Sydney, Australia is leading the world's largest clinical trial exploring how losing weight prior to p...
Tumour formation is a multistep and complex process and the underlying mechanism behind it is still largely unclear. A n...
ABL Bio, Inc., a South Korea-based clinical-stage biotech developing bispecific antibody technology for immuno-oncology ...
